Priavoid successfully completed the first-in-human, phase I-study of PRI-002. The multiple ascending dose study started on December 12th, 2018.
News from March 20th, 2018 at 07 p.m. by German radio station WDR.
News & Events:
Priavoid successfully completed the first-in-human, phase I-study of PRI-002. The multiple ascending dose study started on December 12th, 2018.